Home > Dermatology > AAD 2020 > Hidradenitis Suppurativa/Acne Inversa > HS patients carry higher risk for systemic lupus erythematosus

HS patients carry higher risk for systemic lupus erythematosus


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
AAD 2020
Trial
phase 1
A US cohort study showed a greater likelihood of developing certain connective tissue diseases like morphoea or systemic lupus erythematosus (SLE) in patients already suffering from hidradenitis suppurativa (HS) [1,2]. Associations between HS and various autoimmune conditions including inflammatory bowel diseases or spondyloarthropathies have been reported in the past. A new population-based study focused on the possibility that HS may also be linked to autoimmune pathologies of connective tissue disease (CTD). Data was retrieved from claims files of non-governmental health insurance from 31 December 2002 to 31 December 2017 in the USA. Included were patients with a diagnosis of HS that were compared with a group of non-HS patients with similar risk profiles and comorbidity. The study population included 66,448 patients with and without HS with a mean age of 37 years. About 3 quarters of patients were female, and comorbidities in terms of IBD, psoriasis, o...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on